This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Adverse effects

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Adverse effects are not uncommon even if blood levels are carefully controlled, and patients must be supervised.

Common side effects within the therapeutic range include hand tremor, muscular weakness, nausea, polydipsia, and polyuria. These are not usually dangerous, but may indicate the beginning of the toxic syndrome. Tremor is very common. Thyroid enlargement, hypothyroidism, ECG changes, a diabetes insipidus-like syndrome and depletion of calcium from bone may also take place. The patient may complain of a metallic taste in the mouth due to lithium treatment. Skin rashes may occur.

The toxic syndrome occurs at levels above 1.4 mmol/l, and involves diarrhoea, vomiting, ataxia, nystagmus, dysarthria, confusion, epileptic seizures, which may lead to coma with hypereflexia and increased muscle tone - and in a few patients to irreversible neurological damage. If this syndrome occurs then the lithium salts should be discontinued, the fluid and electrolyte balance corrected, forced diuresis or dialysis, and symptomatic and supportive measures given, e.g. for seizures (1).

Note that there are certain circumstances where the patient is particulary at risk of developing a toxic reaction, which include:

  • impaired renal function
  • dehydration, for example due to diarrhoea and vomiting, or increased perspiration when visiting a hot climate. If the patient becomes dehydrated lithium treatment should be stopped.

The most important drug interaction of lithium is with sodium depleting drugs especially thiazides where significant lithium toxicity may occur. Other drugs which reduce lithium excretion include ACE inhibitors and NSAIDs (1).

Reference:

  • Drug and Therapeutics Bulletin (1999), 37 (3), 22-24.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.